Skip to main content

Semnur Pharmaceuticals, Inc.

corporate_fare Company Profile

Semnur Pharmaceuticals, Inc.

SMNR·OTC·Life Sciences·CIK 0001913577

Our Company is a late-stage clinical biopharmaceutical company that develops and commercializes innovative non-opioid pain management products for acute and chronic pain. The company focuses on indications with high unmet needs and large market opportunities. Its lead product candidate is SP-102 (10 mg, dexamethasone sodium phosphate viscous gel). If approved, SP-102 is designed to be the first U.S. Food and Drug Administration ("FDA") approved non-opioid novel injectable corticosteroid gel formulation for patients with moderate to severe LRP (also known as sciatica). This formulation contains no preservatives, surfactants, solvents, or particulates and is expected to be available in a pre-filled syringe formulation following FDA approval. Founded in 2013, Our Company has invested in its intellectual property portfolio and infrastructure. It has conducted pharmacokinetic ("PK") and toxicology studies, including a Phase 1 PK bridging study, a Phase 2 repeat dose study, and a pivotal Phase 3 study.

Semnur Pharmaceuticals, Inc. (OTC:SMNR) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 13 items for SMNR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 8/10. Across its 13 most recent items scored 7 or higher, the top rating is 10/10, with 11 rated 8 or above. Recent SEC coverage for SMNR spans 10-Q, 424B3, 8-K, SCHEDULE 13D/A.

Recent high-impact activity:

  • Semnur Q3 10-Q: $54K Cash, Going Concern Doubt, $100M iHolding Deal Still Unsigned
  • Semnur Q2 2026: $39k Cash, Going Concern Warning, and a $100M Lifeline Term Sheet
  • Semnur Secures Binding Term Sheet for $100M Strategic Investment at $10.00/Share
  • Semnur Pharmaceuticals Secures $100M Equity Investment at $10/Share, 16x Current Price
  • Semnur Pharmaceuticals Secures Binding Term Sheet for $100M Investment at Significant Premium

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$160.42M
Diluted EPS
-$0.78
Op. Cash Flow
-$5.87M
Operating Income
-$160.42M
Cash & Equivalents
$20K
Debt / Equity
0.00×
Shares Outstanding
230.21M sh
Source: 10-K · filed 2026-02-27 · accession 0001193125-26-082642

Short Interest & Short Volume

12.89 days to cover

FINRA reported short interest of 83,453 shares in SMNR as of the October 30, 2026 settlement, unchanged from the prior period — about 12.9 days to cover at its recent average daily volume. On November 20, 2026, 8.0% of SMNR volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)83,453 shares as of October 30, 2026
Change vs prior period 0.0%
Days to cover12.89 at avg daily volume of 6,473
Daily short volume (FINRA facilities)8.0% of 81,126 shares on November 20, 2026
5-day average short volume11.0%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

High risk

Filing-implied dilution signals for SMNR, detected from its recent SEC filings · based on capital-structure filings through 2026-07-07.

1 recent capital raise

Strategic Investment Secured · Significant Premium Pricing

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with S →
$0.15 -40.00% today
52-week range · as of 2026-11-04 $0.1279 – $23
Market cap
$32.66M
Volume
81.1K (8.8× avg)
3-mo avg 9.2K
Live data · 2026-11-21 15:26 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SMNR - Latest Insights

SMNR
Nov 04, 2026, 4:17 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.430
Real-time Price: $0.150 info
Change: -$0.280 (-65%) info
Market Cap: $32.656M info
SMNR
Aug 10, 2026, 4:54 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.750
Real-time Price: $0.150 info
Change: -$0.600 (-80%) info
Market Cap: $32.656M info
SMNR
Jul 07, 2026, 10:46 AM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $0.600
Real-time Price: $0.150 info
Change: -$0.450 (-75%) info
Market Cap: $32.656M info
SMNR
Jul 07, 2026, 10:43 AM EDT
Source: Wiseek News
Importance Score:
10
Price at Filing: $0.600
Real-time Price: $0.150 info
Change: -$0.450 (-75%) info
Market Cap: $32.656M info
SMNR
Jul 07, 2026, 10:38 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.650
Real-time Price: $0.150 info
Change: -$0.500 (-77%) info
Market Cap: $32.656M info
SMNR
Jul 01, 2026, 6:03 AM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $0.500
Real-time Price: $0.150 info
Change: -$0.350 (-70%) info
Market Cap: $32.656M info
SMNR
Jun 26, 2026, 4:24 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $0.600
Real-time Price: $0.150 info
Change: -$0.450 (-75%) info
Market Cap: $32.656M info
SMNR
Jun 25, 2026, 5:03 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.10
Real-time Price: $0.150 info
Change: -$0.950 (-86%) info
Market Cap: $32.656M info
SMNR
Jun 15, 2026, 5:01 PM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $3.00
Real-time Price: $0.150 info
Change: -$2.85 (-95%) info
Market Cap: $32.656M info
SMNR
Jun 15, 2026, 7:00 AM EDT
Filing Type: 424B3
Importance Score:
9
Price at Filing: $2.80
Real-time Price: $0.150 info
Change: -$2.65 (-95%) info
Market Cap: $32.656M info
SMNR
May 13, 2026, 5:02 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $5.99
Real-time Price: $0.150 info
Change: -$5.84 (-97%) info
Market Cap: $32.656M info
SMNR
Apr 30, 2026, 4:50 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $8.00
Real-time Price: $0.150 info
Change: -$7.85 (-98%) info
Market Cap: $32.656M info
SMNR
Apr 23, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.00
Real-time Price: $0.150 info
Change: -$4.85 (-97%) info
Market Cap: $32.656M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets